Items where Author is "Agirre, X"

MONTIEL-DUARTE, C., CORDEU, L., AGIRRE, X., ROMÁN-GÓMEZ, J., JIMÉNEZ-VELASCO, A., SAN, J.E., GÁRATE, L., ANDREU, E.J., CALASANZ, M.J., HEINIGER, A., TORRES, A. and PRÓSPER, F., 2008. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leukaemia Research, 32 (5), pp. 709-716. ISSN 0145-2126

AGIRRE, X., ROMAN-GOMEZ, J., JIMENEZ-VELASCO, A., GARATE, L., MONTIEL-DUARTE, C., NAVARRO, G., VÁZQUEZ, I., ZALACAIN, M., CALASANZ, M.J., HEINIGER, A., TORRES, A., MINNA, J.D. and PRÓSPER, F., 2006. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene, 25 (13), pp. 1862-1870. ISSN 0950-9232

AGIRRE, X., ROMAN-GOMEZ, J., VAZQUEZ, I., JIMENEZ-VELASCO, A., GARATE, L., MONTIEL-DUARTE, C., ARTIEDA, P., CORDEU, L., LAHORTIGA, I., CALASANZ, M.J., HEINIGER, A., TORRES, A., MINNA, J.D. and PROSPER, F., 2006. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. International Journal of Cancer, 118 (8), pp. 1945-1953. ISSN 0020-7136

AGIRRE, X., FONTALBA, A., ANDREU, E.J., ODERO, M.D., LARRÁYOZ, M.J., MONTIEL, C., CALASANZ, M.J., FERNÁNDEZ-LUNA, J.L. and PRÓSPER, F., 2003. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica, 88 (12), pp. 1425-1426. ISSN 0390-6078